Gian Luca De Salvo

13PUBLICATIONS
71CO-AUTHORS
Gene and molecular therapyTumour immunologyRecommender systemsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 27, 2026
Establishing a Clinical Trial Quality Team in a Comprehensive Cancer Center: A Strategy to Navigate the New European Regulatory Landscape.

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Jul 09, 2025
The International Soft Tissue Sarcoma Consortium: The baseline analysis of rhabdomyosarcoma data.

Gianni Bisogno, Monika Sparber-Sauer, David Rodeberg

|Mar 07, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.

Gianni Bisogno, Julia Chisholm, Raquel Hladun

|Feb 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.

Gian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin

|Dec 23, 2022
Role of SAMITAL in the Prevention and Treatment of Chemo-Radiotherapy-Induced Oral Mucositis in Head and Neck Carcinoma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (ROSAM).

Elena Fasanaro, Paola Del Bianco, Elena Groff

Pageof 3

Frequent Collaborators

6 joint publications

Paola Del Bianco

5 joint publications

Gianni Bisogno

4 joint publications

Véronique Minard-Colin

4 joint publications

Daniel Orbach